Nkarta, Inc. (NKTX) Earnings Signals & AI Vibe Check

Latest Filing: 10-K  |  Filed Mar 25, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for Nkarta, Inc.?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-K, Nkarta, Inc.'s filing signal continuing positive.
earningsVibe SuperAnalyst™ Verdict: CONTINUING POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
Pending
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Continuing Negative
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does Nkarta, Inc. actually do?
Answer:
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. Its lead program, NKX019, is a CAR NK cell candidate targeting CD19 for autoimmune diseases, currently in Phase 1 clinical trials for lupus nephritis, primary membranous nephropathy, systemic sclerosis, idiopathic inflammatory myopathy, and ANCA-associated vasculitis. The company's proprietary platform aims to enhance NK cell expansion, persistence, and targeting, enabling a scalable, on-demand approach to treatment. Nkarta operates two cGMP manufacturing facilities in South San Francisco, California, to support its clinical development and potential commercialization efforts.
Question:
What are Nkarta, Inc.'s revenue drivers?
Answer:
The company has not generated revenue from product sales and expects to continue incurring losses. Future revenue is contingent upon the successful development, regulatory approval, and commercialization of its product candidates.

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required